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34* Tracheal structure abnormalities in Cftr−/− knockout mice
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In contrast to CF patients, respiratory tract of Cftr−/− mice exhibit few pathologic
changes. Among them, we have observed limitations of the respiratory airﬂow.
The aim of this study was to characterize the airﬂow reduction and to investigate
whether this alteration could be explained by morphologic changes in the upper
airways structure. Experiments were performed on adult Cftrtm1Unc knockout
mice (Cftr−/−) and their control littermates (Cftr+/+). Ventilation was measured
in conscious mice breathing room air using body-plethysmography. Results show
that minute ventilation was lower in Cftr−/− than in Cftr+/+ mice because of
a lengthening of both inspiratory and expiratory durations. Subsequently, study
of the tracheal structure was carried out by in situ morphometric analyses and
histological examination of tracheal rings. The length of the trachea/body and
the number of tracheal rings were similar. However, most Cftr−/− mice exhibit
striking abnormalities localised in the proximal part of the trachea with a severe
narrowing, elliptical deformities and numerous frontal disruptions of the cartilage
rings. Histological analysis of tracheal sections revealed marked disorganization of
cartilaginous rings conﬁrming previous macroscopic observations. Similar tracheal
structure alterations were observed in Cftr−/− newborn mice. These ﬁndings suggest
that the reduced respiratory airﬂow can be explained by tracheal constriction and
incomplete cartilage rings of the proximal trachea. These tracheal abnormalities
already present in newborn strongly suggest malformations questioning on the
molecular mechanisms governing tracheal development.
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Cystic ﬁbrosis transmembrane conductance regulatory (CFTR) is highly expressed
in the lung and other organs during development. The role of CFTR in organogenesis
and the effect of its absence on lung structure and function have been largely
overlooked in the pathophysiology of cystic ﬁbrosis. Recently, we demonstrated that
transient in utero loss of CFTR can have signiﬁcant effects of lung and intestine
function in the adult and that CFTR is involved in stretch induced differentiation
of both the lung and intestines.
In work to be presented we show that the developmental effect of transient in
utero CFTR deﬁciency in the lung and intestines results in progressive disease. The
lung function degenerates over time, intestinal metabolic activity is altered, and CF
related diabetes occurs. These changes are shown to be directly related to changes
in cell function due to immaturity and developmental arrest. Type II cell function
is altered and changes in surfactant production occurs in the presence of a normal
CFTR phenotype postnatally. In the intestines changes in metabolic activity lead to
altered glucose metabolism and degeneration of pancreatic function.
These late onset pathologies following transient in utero inhibition of CFTR are
consistent with CF belonging to a group of diseases we have termed “Peter Pan
Diseases”. Failure to complete organogenesis due to a deﬁciency of CFTR results
in retention of a immature cell phenotype that leads to decreased functionality and
disease in the adult.
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Measurement of ASL in man would be useful both for understanding of CF patho-
physiology as well as a potential biomarker for therapeutic trials. We have assessed
the feasibility of measuring ASL in CF and non-CF nasal (NB) and bronchial
biopsies (BB). We analysed 16 non-CF and 6 CF NB, assessing 20−30 sections per
biopsy. ASL height could be measured in all non-CF samples and approximately
50% of the CF biopsies, the rest not having adequate areas of ciliated epithelium.
However, in addition, a stable cumulative mean derived from the number of cells
available for counting, could only be achieved in 45% of the biopsies irrespective
of genotype. Thus, only approximately one quarter of CF nasal biopsies taken were
available for analysis. We also assessed 28 non-CF and 17 CF BB. 50% of biopsies
from either genotype were suitable for ASL height assessment. Subsequently, a
stable cumulative mean could be derived from only 20% of samples. Thus, only
approximately one tenth of CF bronchial biopsies taken were suitable for analysis.
Analysis of ASL height is also very labour intensive, requiring approximately 2 days
of laboratory time per biopsy. We conclude that this assay will require both large
patient numbers (approximately 50 biopsies/group) and extensive manpower, to
conﬁrm the approximately 0.5mm reduction in ASL height observed by our group,
and others, in the CF mouse nose.
Supported by: CF Trust.
37 Effect of mist tent on ion content of nasal ﬂuid in patients with
cystic ﬁbrosis
I. Kozlova1, V. Adermark2, L. Hjelte2, G. Roomans1. 1Medical Cell Biology,
Univ of Uppsala, Uppsala, Sweden; 2Stockholm CF Center, Karolinska Univ Hosp
Huddinge, Stockholm, Sweden
Mist tents were recommended for CF patients in the 1960s and 1970s in order to
hydrate their viscous mucus. However, the efﬁciency of the method was doubted
and its use largely discontinued. We have measured the effect of sleeping in a mist
tent on the ion content of nasal airway surface liquid (ASL) in CF-patients and
healthy controls by using a recently available method. The CF patients and controls
spent 8 h in a mist tent. Samples of the nasal ASL were taken with Sephadex G-25
beads mounted on ﬁlter paper, and analyzed by X-ray microanalysis in the scanning
electron microscope, before the experiment, after 8 h in the tent, and then at each
hour during 4 h after the persons had left the tent. In an initial experiment, samples
were taken from a healthy control every 2 h during 8 h, and then every 24 h during
two days.
CF patients had signiﬁcantly higher levels of Na, Cl, and K in their nasal ASL
compared to controls, in agreement with previous results. Immediately after and
at 2 h after leaving the tent, the concentrations of Na, Cl, and K had decreased
in CF-patients and in controls. At that time, there was no difference in elemental
content between CF-patients and controls. However, at 4h after leaving the tent, the
levels of K and Cl, but not of Na, were signiﬁcantly increased in CF-patients, but
not in controls. The levels of Cl and K in CF-patients were similar to the levels
determined before the patient went into the tent. In the preliminary experiment on
the control no major changes in ion content of the ASL occurred after 4 h.
Conclusion: sleeping in a mist tent lowers the ion content of the nasal ASL, which
may improve its bactericidal properties, but the effect is short-lived.
